The findings indicate that the expression of TTYH3 may affect the phosphorylation of FGFR1, inhibit H-Ras/A-Raf/MEK signaling, and inhibit the proliferation of bladder cancer cells. This evidence concerns the gene HRAS and urinary bladder carcinoma.